Connecticut Says McKesson Inflated Drug Prices

Law360, New York (May 29, 2008, 12:00 AM EDT) -- The state of Connecticut has joined the wide-ranging average wholesale price litigation, accusing McKesson Corp. of conspiring with First DataBank Inc. to manipulate the wholesale drug prices that are used to determine the rates for private and public health insurers.

McKesson and First DataBank schemed to inflate the AWP of more than 400 brand-name drugs to 25% over the wholesale acquisition cost, Connecticut claimed in the lawsuit, filed on Wednesday in the U.S. District Court for the District of Massachusetts.

The state's complaint echoed allegations that...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.